| 23-May-13 08:18AM | Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi at theflyonthewall.com |
| 08:00AM | Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-121 in Combination With Exemestane in Breast Cancer GlobeNewswire |
| 22-May-13 02:51PM | Thrifty Merrimack developing new cancer drugs at lower cost at Reuters |
| 17-May-13 01:04PM | MERRIMACK PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 15-May-13 07:03PM | Merrimack's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 13-May-13 10:00AM | Merrimack Reports First Quarter 2013 Financial Results GlobeNewswire |
| 07:07AM | Q1 2013 Merrimack Pharmaceuticals Inc Earnings Release - Time Not Supplied CCBN |
| 06:59AM | Dimon Talks of Quitting, Post Cereal Jumps Ahead of Earnings Hot Stock Minute |
| 03:10AM | MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online |
| 05-May-13 01:23PM | Predicting Biotech Stock Moves Using Top Consensus Picks By Legendary Fund Managers at Seeking Alpha |
| 02-May-13 08:00AM | Merrimack to Present at Multiple Investor Conferences This Spring GlobeNewswire |
| 01-May-13 11:10AM | Boris Peaker, Executive Director and Senior Analyst at Oppenheimer & Co. Inc., Interviews with The Wall Street Transcript: Finding Innovation in Biotechnology for Cell Therapy, Oncology and Orphan Drugs Wall Street Transcript -8.54% |
| 30-Apr-13 10:00AM | Merrimack Pharmaceuticals Announces Timing of First Quarter 2013 Investor Conference Call GlobeNewswire |
| 29-Apr-13 08:36AM | Merrimack Pharmaceuticals Completes Enrollment of Second Cohort in Phase 2 Study of MM-121 in Non-Small Cell Lung Cancer GlobeNewswire |
| 24-Apr-13 06:02PM | Nasdaq stocks posting largest percentage decreases AP -7.79% |
| 01:28PM | Nasdaq stocks posting largest percentage decreases AP |
| 12:36PM | Merrimack Pharmaceuticals Getting Very Oversold (MACK) at TheStreet |
| 15-Apr-13 08:00AM | Merrimack Pharmaceuticals Completes Enrollment of One Cohort in Neoadjuvant Phase 2 Study of MM-121 in HER2-Negative Breast Cancer GlobeNewswire |
| 10-Apr-13 09:06AM | InPlay: Merrimack Pharma's preclinical research shows MM-111 restores sensitivity to chemotherapy and HER2-targeted treatment in gastric cancer model Briefing.com |
| 09:00AM | Merrimack Pharmaceuticals' Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy And HER2-targeted Treatment In Gastric Cancer Model PR Newswire |
| 08-Apr-13 08:03AM | InPlay: Merrimack Pharma preclinical research shows MM-121 restores sensitivity to anti-estrogen therapy and delays onset of treatment resistance in ER-Positive breast cancer model Briefing.com |
| 05-Apr-13 12:11PM | Merrimack Pharmaceuticals Announces Webcast of Inaugural Research & Development Day GlobeNewswire |
| 04-Apr-13 09:05AM | Stocks to Watch: CombiMatrix, Merrimack, Compuware at The Wall Street Journal |
| 08:31AM | Merrimack lung cancer drug fails goal in one mid-stage trial group at Reuters |
| 08:03AM | InPlay: Merrimack Pharma announces top-line results from a single arm Phase 2 advanced lung cancer study in patients with resistance to an anti-EGFR tyrosine kinase inhibitor -- one cohort of a Phase 2 non-small cell lung cancer study did n Briefing.com |
| 02-Apr-13 09:00AM | Merrimack Pharmaceuticals To Present Preclinical Research On Five Novel Cancer Therapies PR Newswire |
| 27-Mar-13 06:35AM | Buy Hercules Tech Growth Capital Instead Of OCZ Tech at Seeking Alpha |
| 26-Mar-13 01:04PM | MERRIMACK PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 21-Mar-13 06:46AM | The Zacks Analyst Blog Highlights: Merrimack Pharmaceuticals, Bristol-Myers Squibb, Sanofi, Novo Nordisk and Hewlett-Packard Zacks |
| 20-Mar-13 03:58PM | Sanofi/MACK Candidate Progresses Zacks |
| 03:02PM | Why Merrimack Is Poised to Outperform at Motley Fool |
| 07:39AM | MERRIMACK PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 18-Mar-13 01:40PM | Merrimack May Be Right For Your Portfolio at Motley Fool |
| 09:03AM | InPlay: Merrimack Pharma completes enrollment in a Phase 2 Study of MM-121 in combination with Paclitaxel in patients with platinum-resistant or refractory advanced ovarian cancers Briefing.com |
| 08:17AM | Merrimack completes enrollment in Phase 2 study of MM-121 in collaboration with Sanofi theflyonthewall.com |
| 08:00AM | Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-121 in Combination With Paclitaxel in Patients With Platinum-Resistant or Refractory Advanced Ovarian Cancers GlobeNewswire |
| 16-Mar-13 07:32PM | New Star Analyst Rankings for Merrimack Pharmaceuticals, Inc. StarMine |
| 15-Mar-13 07:41PM | New Star Analyst Rankings for Merrimack Pharmaceuticals, Inc. StarMine |
| 14-Mar-13 03:31PM | Merrimack Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 08:20AM | MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online |
| 08:00AM | Merrimack Reports Fourth Quarter and Full Year 2012 Financial Results GlobeNewswire |
| 07:07AM | Q4 2012 Merrimack Pharmaceuticals Inc Earnings Release - Before Market Open CCBN |
| 08-Mar-13 08:09AM | Why These 4 Biotechs Could Be Next In Line To See Their Share Prices Rise at Seeking Alpha |
| 06-Mar-13 02:24PM | Merrimack's CEO Presents at 33rd Annual Cowen & Co. Health Care Conference (Transcript) at Seeking Alpha |
| 08:20AM | Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success in 2012 Marketwire |
| 28-Feb-13 06:36AM | 3 Bio-Pharmaceuticals Insiders Love at Motley Fool |
| 27-Feb-13 09:14AM | Merrimack Pharmaceuticals Announces Timing of Fourth Quarter 2012 Investor Conference Call GlobeNewswire |
| 25-Feb-13 12:31PM | Merrimack to Present at the Cowen and Company 33rd Annual Health Care Conference GlobeNewswire |
| 13-Feb-13 03:15PM | 3 Events Biotech Investors Need to Watch in 2013 at Motley Fool |
| 07-Feb-13 12:42PM | Merrimack to Participate in Pancreatic Cancer Panel at the 2013 BIO CEO & Investor Conference GlobeNewswire |
| 23-Jan-13 08:19AM | Merrimack Pharmaceuticals to Present Preclinical Data on Bispecific Antibody MM-111 in ErbB2-Positive Gastric Cancers GlobeNewswire |
| 11-Jan-13 02:32PM | 4 Biotech Stocks With Insider Interest at Motley Fool |
| 29-Dec-12 01:34PM | 3 Things to Watch at Merrimack at Motley Fool |
| 19-Dec-12 02:53PM | InPlay from Briefing.com Briefing.com -5.81% |
| 02:19PM | InPlay from Briefing.com Briefing.com |
| 02:14PM | InPlay: Merrimack Pharma initiates cross-tumor study to investigate potential predictive response markers for a developmental nanotherapeutic chemotherapy Briefing.com |
| 02:14PM | 2012 Review: Merrimack Pharmaceuticals at Motley Fool |
| 02:11PM | Merrimack Pharmaceuticals Initiates Cross-Tumor Study to Investigate Potential Predictive Response Markers for a Developmental Nanotherapeutic Chemotherapy GlobeNewswire |
| 17-Dec-12 10:46AM | MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an EDGAR Online |
| 14-Dec-12 08:03PM | Here's What This $4 Billion Hedge Fund Has Been Buying at Motley Fool |
| 13-Dec-12 08:33PM | Cancer Stocks at Forbes |
| 03:47PM | 1 Catalyst Biotech Investors Need to Watch at Motley Fool |
| 12-Dec-12 10:30AM | InPlay: Merrimack Pharma initiates Phase 1 clinical study of MM-141 in patients with advanced solid tumors Briefing.com |
| 10:30AM | Merrimack Pharmaceuticals Initiates Phase 1 Clinical Study of MM-141 in Patients With Advanced Solid Tumors GlobeNewswire |
| 11-Dec-12 06:02PM | Nasdaq stocks posting largest percentage decreases AP +6.08% |
| 01:44PM | Nasdaq stocks posting largest percentage decreases AP |
| 10-Dec-12 06:02PM | Nasdaq stocks posting largest percentage decreases AP |
| 01:27PM | Nasdaq stocks posting largest percentage decreases AP |
| 09:05AM | InPlay: Merrimack Pharma presents 'promising' Phase I clinical data for novel agent to treat HER2-positive breast cancer and preclinical data on companion diagnostic Briefing.com |
| 09:04AM | Merrimack Pharmaceuticals Presents Promising Phase I Clinical Data for Novel Agent to Treat HER2-positive Breast Cancer and Preclinical Data on Companion Diagnostic PR Newswire |
| 06:00AM | 'Mad Money' Lightning Round: Buy, Buy, Buy Cabella's, UnitedHealthcare at TheStreet |
| 07-Dec-12 06:40PM | [video] Lightning Round at CNBC -7.46% |
| 06:05PM | Nasdaq stocks posting largest percentage decreases AP |
| 06-Dec-12 01:26PM | Does Merrimack Pharmaceuticals Have A Blockbuster Drug With MM-398? at Seeking Alpha |
| 08:07AM | 4 Biotechs With Poor Balance Sheets at Seeking Alpha |
| 05-Dec-12 10:59AM | Merrimack Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference GlobeNewswire |
| 03-Dec-12 12:52PM | Merrimack Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference GlobeNewswire |
| 08:22AM | Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012 Marketwire |
| 08:20AM | Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012 Marketwire |
| 20-Nov-12 01:04PM | MERRIMACK PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 19-Nov-12 01:37PM | Merrimack Pharmaceuticals to Present at the J.P. Morgan SMid Cap Conference GlobeNewswire |
| 15-Nov-12 09:30AM | New Star Analyst Rankings for Merrimack Pharmaceuticals, Inc. StarMine |
| 14-Nov-12 09:30AM | MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations a EDGAR Online |
| 08:09AM | InPlay: Merrimack Pharma beats by $0.01; beats on revs Briefing.com |
| 08:00AM | Merrimack Pharmaceuticals Reports Third Quarter 2012 Financial Results GlobeNewswire |
| 07:07AM | Q3 2012 Merrimack Pharmaceuticals Inc Earnings Release - Time Not Supplied CCBN |
| 06-Nov-12 11:34AM | Merrimack Pharmaceuticals to Present at Lazard Capital Markets' 9th Annual Healthcare Conference GlobeNewswire +6.20% |
| 05-Nov-12 08:00AM | Merrimack Pharmaceuticals Announces Timing of Third Quarter 2012 Investor Conference Call GlobeNewswire |
| 31-Oct-12 04:00PM | Merrimack Pharmaceuticals to Present Preclinical Data at the 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics GlobeNewswire |
| 04-Oct-12 02:32PM | Why Does Billionaire Thomas Steyers Farallon Love This Pharmaceutical Company? at Motley Fool |
| 02-Oct-12 08:30AM | Merrimack Pharmaceuticals' Therapies Show Promise In Certain Advanced Breast, Gastric And Gynecologic Cancers PR Newswire |
| 27-Sep-12 06:45AM | Merrimack initiated with a Buy at Brean Murray at theflyonthewall.com |
| 26-Sep-12 06:04PM | Nasdaq stocks posting largest volume increases AP |
| 06:04PM | Nasdaq stocks posting largest percentage decreases AP |
| 01:25PM | Nasdaq stocks posting largest percentage decreases AP |
| 25-Sep-12 06:10PM | Nasdaq stocks posting largest volume increases AP -16.91% |
| 06:10PM | Nasdaq stocks posting largest percentage decreases AP |
| 04:39PM | U.S. Stocks Fall Amid Concern Over Stimulus Efforts at Bloomberg |
| 01:18PM | Nasdaq stocks posting largest percentage decreases AP |
| 22-Sep-12 09:09AM | 5 Low-Debt Biotech Stocks Forecasted For Growth at Seeking Alpha |
